ロード中...
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Loss-of-function mutations in BRCA1 and BRCA2 are detected in at least 5% of unselected patients with breast cancer (BC). These BC susceptibility genes encode proteins critical for DNA homologous recombination repair (HRR). This review provides an update on oral poly(ADP-ribose) polymerase (PARP) in...
保存先:
| 出版年: | Target Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8105250/ https://ncbi.nlm.nih.gov/pubmed/33710534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-021-00796-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|